A number of other research firms have also issued reports on REL. UBS Group reissued a sell rating and issued a GBX 1,550 ($20.25) price target on shares of Relx in a research report on Thursday, October 25th. Barclays raised their price objective on shares of Relx from GBX 1,600 ($20.91) to GBX 1,615 ($21.10) and gave the company an equal weight rating in a research report on Friday, July 6th. Citigroup reaffirmed a neutral rating on shares of Relx in a research report on Wednesday, July 25th. Numis Securities reaffirmed a hold rating on shares of Relx in a research report on Thursday, July 26th. Finally, Berenberg Bank reaffirmed a buy rating and set a GBX 1,800 ($23.52) price objective on shares of Relx in a research report on Monday, October 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company. Relx presently has a consensus rating of Buy and an average price target of GBX 1,780.77 ($23.27).
LON REL opened at GBX 1,530 ($19.99) on Thursday. Relx has a 52-week low of GBX 1,399 ($18.28) and a 52-week high of GBX 1,784 ($23.31).
RELX PLC provides information and analytics for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals.
Recommended Story: How is an ETF different from a mutual fund?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.